Hasil Pencarian - Parameswaran Hari
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 20 hasil dari 38
- Ke Halaman Berikutnya
-
1
Recent advances in understanding multiple myeloma [version 1; referees: 4 approved] oleh Binod Dhakal, Saulius Girnius, Parameswaran Hari
Diterbitkan 2016-08-01Dapatkan teks lengkap
Artikel -
2
Plegia to walking: AHSCBMT in severe NMOSD relapse oleh Nicola Carlisle, Parameswaran Hari, Staley Brod
Diterbitkan 2020-12-01Dapatkan teks lengkap
Artikel -
3
-
4
Biomarkers in individualized management of chimeric antigen receptor T cell therapy oleh Mengyi Du, Parameswaran Hari, Yu Hu, Heng Mei
Diterbitkan 2020-05-01Dapatkan teks lengkap
Artikel -
5
Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies oleh Nirav N. Shah, Theresa Maatman, Parameswaran Hari, Bryon Johnson
Diterbitkan 2019-03-01Dapatkan teks lengkap
Artikel -
6
-
7
-
8
Development of Novel Immunotherapies for Multiple Myeloma oleh Ensaf M. Al-Hujaily, Robyn A. A. Oldham, Parameswaran Hari, Jeffrey A. Medin
Diterbitkan 2016-09-01Dapatkan teks lengkap
Artikel -
9
-
10
-
11
-
12
-
13
Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline... oleh Anita D'Souza, Kathryn Flynn, Saurabh Chhabra, Binod Dhakal, Mehdi Hamadani, Kirsten Jacobsen, Marcelo Pasquini, Dorothee Weihrauch, Parameswaran Hari
Diterbitkan 2017-12-01Dapatkan teks lengkap
Artikel -
14
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study oleh Jing Dong, Zhuping Garacci, Christopher Staffi Buradagunta, Anita D’Souza, Meera Mohan, Ashley Cunningham, Siegfried Janz, Binod Dhakal, Aaron P. Thrift, Parameswaran Hari
Diterbitkan 2022-02-01Dapatkan teks lengkap
Artikel -
15
Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study oleh Christopher Staffi Buradagunta, Zhuping Garacci, Anita D’Souza, Binod Dhakal, Sumana Devata, Siegfried Janz, Aaron P. Thrift, Parameswaran Hari, Melinda Stolley, Jing Dong
Diterbitkan 2022-05-01Dapatkan teks lengkap
Artikel -
16
P1082: RESULTS FROM A PHASE 1/2 STUDY OF TANDEM, BISPECIFIC ANTI-CD20/ANTI-CD19 (LV20.19) CAR T-CELLS FOR MANTLE CELL LYMPHOMA oleh Nirav N Shah, Timothy Fenske, Bryon Johnson, Aniko Szabo, Sumana Devata, Walter Longo, Tyce Kearl, Anthony Zamora, Parameswaran Hari, Dina Schneider, Mehdi Hamadani
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
17
WDR26 and MTF2 are therapeutic targets in multiple myeloma oleh Fumou Sun, Yan Cheng, Jesse D. Riordan, Adam Dupuy, Wendy Dubois, Michael Pisano, Jing Dong, Beverly Mock, Fenghuang Zhan, Parameswaran Hari, Siegfried Janz
Diterbitkan 2021-12-01Dapatkan teks lengkap
Artikel -
18
Germline Risk Contribution to Genomic Instability in Multiple Myeloma oleh Siegfried Janz, Fenghuang Zhan, Fenghuang Zhan, Fumou Sun, Yan Cheng, Michael Pisano, Michael Pisano, Ye Yang, Ye Yang, Hartmut Goldschmidt, Hartmut Goldschmidt, Parameswaran Hari
Diterbitkan 2019-05-01Dapatkan teks lengkap
Artikel -
19
Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma oleh Michael Pisano, Michael Pisano, Yan Cheng, Fumou Sun, Binod Dhakal, Anita D’Souza, Saurabh Chhabra, Jennifer M. Knight, Sridhar Rao, Sridhar Rao, Fenghuang Zhan, Parameswaran Hari, Siegfried Janz
Diterbitkan 2021-06-01Dapatkan teks lengkap
Artikel -
20
S203: QUADRUPLET INDUCTION THERAPY, ASCT AND MRD-MODULATED CONSOLIDATION AND TREATMENT CESSATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF THE MASTER TRIAL oleh Luciano Costa, Eva Medvedova, Sarabh Chhabra, Bhagirathbhai Dholaria, Binod Dhakal, Kelly Godby, Rebecca Silberman, Susan Bal, Anita D’souza, Smith Giri, Timothy Schmidt, James Omel, Parameswaran Hari, Natalie Callander
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel